Authors: Keane, WF Brenner, BM Mazzu, A Agro, A

Citation: Wf. Keane et al., The CHORUS (Cerivastatin in heart outcomes in renal disease Understanding survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD, AM J KIDNEY, 37(1), 2001, pp. S48-S53

Authors: Mazzu, A

Citation: A. Mazzu, Motor syntax and corporal stylistics - Reflections on the bodily schema inthe early work of Merleau-Ponty, REV PHILOS, 99(1), 2001, pp. 46-72

Authors: Isaacsohn, J Zinny, M Mazzu, A Lettieri, J Heller, AH

Citation: J. Isaacsohn et al., Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults, EUR J CL PH, 56(12), 2001, pp. 897-903

Authors: Muck, W Ochmann, K Mazzu, A Lettieri, J

Citation: W. Muck et al., Biopharmaceutical profile of cerivastatin: a novel HMG-CoA reductase inhibitor, J INT MED R, 27(3), 1999, pp. 107-114

Authors: Stein, E Isaacsohn, J Stoltz, R Mazzu, A Liu, MC Lane, C Heller, AH

Citation: E. Stein et al., Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mgdose of cerivastatin in patients with primary hypercholesterolemia, AM J CARD, 83(10), 1999, pp. 1433-1436